Trellis Bioscience LLC
Overview
Trellis Bioscience LLC develops human monoclonal antibodies (mAbs) for the treatment of infectious diseases and cancer, leveraging its proprietary CellSpot™ platform for discovery. The company is conducting clinical trials for its lead product, TRL1068, aimed at treating prosthetic joint infections.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Trellis Bioscience LLC in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Trellis Bioscience LLC?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.